Literature DB >> 15060526

Small-molecule inhibitors of protein-protein interactions: progressing towards the dream.

Michelle R Arkin1, James A Wells.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15060526     DOI： 10.1038/nrd1343

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  489 in total

1.  Allosteric inhibition of the regulator of G protein signaling-Galpha protein-protein interaction by CCG-4986.

Authors:  David L Roman; Levi L Blazer; C Aaron Monroy; Richard R Neubig
Journal:  Mol Pharmacol       Date:  2010-06-07       Impact factor: 4.436

Review 2.  Molecular targeting of angiogenesis for imaging and therapy.

Authors:  Simon S Brack; Ludger M Dinkelborg; Dario Neri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-08-05       Impact factor: 9.236

3.  An in vitro Förster resonance energy transfer-based high-throughput screening assay for inhibitors of protein-protein interactions in SUMOylation pathway.

Authors:  Yang Song; Jiayu Liao
Journal:  Assay Drug Dev Technol       Date:  2011-12-22       Impact factor: 1.738

Review 4.  Biology in a gray box: targeting the emergent properties of protein complexes: 2011 Yale Chemical Biology Symposium.

Authors:  Victor Wong
Journal:  Yale J Biol Med       Date:  2011-12

Review 5.  Evolution of immunity: no development without risk.

Authors:  Alexander B Sigalov
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

Review 6.  BRCA1-directed, enhanced and aberrant homologous recombination: mechanism and potential treatment strategies.

Authors:  Seth M Dever; E Railey White; Matthew C T Hartman; Kristoffer Valerie
Journal:  Cell Cycle       Date:  2012-02-15       Impact factor: 4.534

7.  Protein recognition: Calixarene connection.

Authors:  Thomas Schrader
Journal:  Nat Chem       Date:  2012-06-21       Impact factor: 24.427

Review 8.  Antibody-enabled small-molecule drug discovery.

Authors:  Alastair D G Lawson
Journal:  Nat Rev Drug Discov       Date:  2012-06-29       Impact factor: 84.694

9.  CBFbeta is critical for AML1-ETO and TEL-AML1 activity.

Authors:  Liya Roudaia; Matthew D Cheney; Ekaterina Manuylova; Wei Chen; Michelle Morrow; Sangho Park; Chung-Tsai Lee; Prabhjot Kaur; Owen Williams; John H Bushweller; Nancy A Speck
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

Review 10.  Synthetic molecules: helping to unravel plant signal transduction.

Authors:  Wei Xuan; Evan Murphy; Tom Beeckman; Dominique Audenaert; Ive De Smet
Journal:  J Chem Biol       Date:  2013-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.